Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations

Journal of General Internal Medicine

Volumn 27, Issue 6, 2012, Pages 730-738

  Dinh, Tuan A ^a   Alperin, Peter ^a   Walter, Louise C ^b   Smith, Robert ^c  

^a Archimedes Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

Author keywords

colorectal cancer screening; comorbidity; cost effectiveness analysis; health care modeling; individualized guidelines; optimal screening cessation

Indexed keywords

ADULT; AGED; CANCER REGISTRY; CANCER SCREENING; CLINICAL TRIAL (TOPIC); COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA BASE; DIABETES MELLITUS; DIABETIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; QUALITY ADJUSTED LIFE YEAR; REVIEW; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; COLONOSCOPY; COLORECTAL NEOPLASMS; COMORBIDITY; COST-BENEFIT ANALYSIS; DIABETES MELLITUS; EARLY DETECTION OF CANCER; HEALTH CARE COSTS; HUMANS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY-ADJUSTED LIFE YEARS;

EID: 84862828572     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-011-1972-6     Document Type: Review

References (68)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer Statistics, 2010. CA Cancer J Clin.
2. JS Mandel JH Bond TR Church DC Snover GM Bradley LM Schuman, et al. 1993 Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study N Engl J Med. 328 19 1365 71 8474513 10.1056/NEJM199305133281901 1:STN:280:DyaK3s3jtlOhtQ%3D%3D
3. JV Selby GD Friedman CP Quesenberry Jr NS Weiss 1992 A case-control study of screening sigmoidoscopy and mortality from colorectal cancer N Engl J Med. 326 10 653 7 1736103 10.1056/NEJM199203053261001 1:STN:280:DyaK387ktVClsg%3D%3D
4. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet;375(9726):1624-33.
5. LC Walter K Lindquist S Nugent T Schult SJ Lee MA Casadei, et al. 2009 Impact of age and comorbidity on colorectal cancer screening among older veterans Ann Intern Med 150 7 465 73 19349631
6. AG Zauber I Lansdorp-Vogelaar AB Knudsen J Wilschut M van Ballegooijen KM Kuntz 2008 Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force Ann Intern Med 149 9 659 69 18838717
7. Calkins E, Boult C, Wagner E. New ways to care for older people. Building systems based on evidence. New York: Springer; 1999.
8. KM Narayan JP Boyle TJ Thompson SW Sorensen DF Williamson 2003 Lifetime risk for diabetes mellitus in the United States JAMA. 290 14 1884 90 14532317 10.1001/jama.290.14.1884 1:CAS:528:DC%2BD3sXotVWnsr4%3D
9. OH Franco EW Steyerberg FB Hu J Mackenbach W Nusselder 2007 Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease Arch Intern Med. 167 11 1145 51 17563022 10.1001/archinte.167.11.1145
10. CP Gross GJ McAvay HM Krumholz AD Paltiel D Bhasin ME Tinetti 2006 The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening Ann Intern Med 145 9 646 53 17088577
11. SC Larsson E Giovannucci A Wolk 2005 Diabetes and colorectal cancer incidence in the cohort of Swedish men Diabetes Care. 28 7 1805 7 15983343 10.2337/diacare.28.7.1805
12. SC Larsson N Orsini A Wolk 2005 Diabetes mellitus and risk of colorectal cancer: a meta-analysis J Natl Cancer Inst. 97 22 1679 87 16288121 10.1093/jnci/dji375
13. NM Gatto H Frucht V Sundararajan JS Jacobson VR Grann AI Neugut 2003 Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study J Natl Cancer Inst. 95 3 230 6 12569145 10.1093/jnci/95.3.230
14. B Levin DA Lieberman B McFarland KS Andrews D Brooks J Bond, et al. 2008 Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology Gastroenterology. 134 5 1570 95 18384785 10.1053/j.gastro.2008.02. 002 1:CAS:528:DC%2BD1cXntVWgs74%3D
15. Kahn R, Alperin P, Eddy D, Borch-Johnsen K, Buse J, Feigelman J, et al. Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis. Lancet;375(9723):1365-74.
16. L Schlessinger DM Eddy 2002 Archimedes: a new model for simulating health care systems-the mathematical formulation J Biomed Inform. 35 1 37 50 12415725 10.1016/S1532-0464(02)00006-0
17. D Eddy L Schlessinger R Kahn B Peskin R Schiebinger 2009 Relationship of insulin resistance and related metabolic variables to coronary artery disease: a mathematical analysis Diabetes Care. 32 2 361 6 19017770 10.2337/dc08-0854 1:CAS:528:DC%2BD1MXis1WrsLo%3D
18. DM Eddy L Schlessinger 2003 Archimedes: a trial-validated model of diabetes Diabetes Care. 26 11 3093 101 14578245 10.2337/diacare.26.11.3093
19. DM Eddy L Schlessinger R Kahn 2005 Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes Ann Intern Med 143 4 251 64 16103469
20. DM Eddy L Schlessinger 2003 Validation of the archimedes diabetes model Diabetes Care. 26 11 3102 10 14578246 10.2337/diacare.26.11.3102
21. Clinical Outcomes Research Initiative, www.cori.org. 2007 (Accessed December 2011).
22. Surveillance Epidemiology and End Results (SEER) Program Populations (1969-2006) ( www.seer.cancer.gov/popdata ) NCI, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released February 2009. (Accessed December 2011).
23. M Tobi 1999 Polyps as biomarkers for colorectal neoplasia Front Biosci. 4 D329 38 10077546 10.2741/Tobi 1:STN:280:DyaK1M7nvFSlug%3D%3D
24. CM Rutter O Yu DL Miglioretti 2007 A hierarchical non-homogenous Poisson model for meta-analysis of adenoma counts Stat Med. 26 1 98 109 16372387 10.1002/sim.2460
25. S Welin J Youker JS Spratt Jr 1963 The Rates and Patterns of Growth of 375 Tumors of the Large Intestine and Rectum Observed Serially by Double Contrast Enema Study (Malmoe Technique) Am J Roentgenol Radium Ther Nucl Med. 90 673 87 14068399 1:STN:280:DyaF2c%2Fis1Sgsw%3D%3D
26. S Bolin E Nilsson R Sjodahl 1983 Carcinoma of the colon and rectum-growth rate Ann Surg. 198 2 151 8 6870372 10.1097/00000658-198308000-00007 1:STN:280:DyaL3s3lsFCgtQ%3D%3D
27. N Umetani T Masaki T Watanabe S Sasaki K Matsuda T Muto 2000 Retrospective radiographic analysis of nonpedunculated colorectal carcinomas with special reference to tumor doubling time and morphological change Am J Gastroenterol. 95 7 1794 9 10925987 10.1111/j.1572-0241.2000.02174.x 1:STN:280:DC%2BD3cvgvVWlug%3D%3D
28. T Matsui S Tsuda K Yao A Iwashita T Sakurai T Yao 2000 Natural history of early colorectal cancer: evolution of a growth curve Dis Colon Rectum. 43 10 Suppl S18 22 11052473 10.1007/BF02237221 1:STN:280:DC%2BD3crgtl2hsQ%3D%3D
29. SJ Winawer AG Zauber MN Ho MJ O'Brien LS Gottlieb SS Sternberg, et al. 1993 Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup N Engl J Med. 329 27 1977 81 8247072 10.1056/ NEJM199312303292701 1:STN:280:DyaK2c%2Fmslamug%3D%3D
30. SJ Winawer BJ Flehinger D Schottenfeld DG Miller 1993 Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy J Natl Cancer Inst. 85 16 1311 8 8340943 10.1093/jnci/85.16.1311 1:STN:280: DyaK3szktFSitQ%3D%3D
31. A Chao CJ Connell V Cokkinides EJ Jacobs EE Calle MJ Thun 2004 Underuse of screening sigmoidoscopy and colonoscopy in a large cohort of US adults Am J Public Health. 94 10 1775 81 15451749 10.2105/AJPH.94.10.1775
32. S Higginbotham ZF Zhang IM Lee NR Cook E Giovannucci JE Buring, et al. 2004 Dietary glycemic load and risk of colorectal cancer in the Women's Health Study J Natl Cancer Inst. 96 3 229 33 14759990 10.1093/jnci/djh020 1:CAS:528:DC%2BD2cXhtVKkurk%3D
33. SA Beresford KC Johnson C Ritenbaugh NL Lasser LG Snetselaar HR Black, et al. 2006 Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial JAMA. 295 6 643 54 16467233 10.1001/jama.295.6.643 1:CAS:528:DC%2BD28XhtF2msb8%3D
34. WS Atkin R Edwards I Kralj-Hans K Wooldrage AR Hart JM Northover, et al. 2010 Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial Lancet. 375 9726 1624 33 20430429 10.1016/S0140-6736(10)60551-X
35. DA Lieberman DG Weiss JH Bond DJ Ahnen H Garewal G Chejfec 2000 Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380 N Engl J Med. 343 3 162 8 10900274 10.1056/NEJM200007203430301 1:STN:280:DC%2BD3czksVemsA%3D%3D
36. SJ Winawer AG Zauber RH Fletcher JS Stillman MJ O'Brien B Levin, et al. 2006 Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society CA Cancer J Clin 56 3 143 59 16737947 10.3322/canjclin.56.3.143 quiz 84-5
37. JE Siegel MC Weinstein LB Russell MR Gold 1996 Recommendations for reporting cost-effectiveness analyses Panel on Cost-Effectiveness in Health and Medicine. JAMA. 276 16 1339 41 1:STN:280:DyaK2s%2FhsFWltA%3D%3D
38. RA Hirth ME Chernew E Miller AM Fendrick WG Weissert 2000 Willingness to pay for a quality-adjusted life year: in search of a standard Med Decis Making. 20 3 332 42 10929856 10.1177/0272989X0002000310 1:STN:280: DC%2BD3M%2FjvVOnsA%3D%3D
39. RS Braithwaite DO Meltzer JT King Jr D Leslie MS Roberts 2008 What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Med Care. 46 4 349 56 18362813 10.1097/MLR. 0b013e31815c31a7
40. I Lansdorp-Vogelaar M van Ballegooijen AG Zauber JD Habbema EJ Kuipers 2009 Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening J Natl Cancer Inst. 101 20 1412 22 19779203 10.1093/jnci/djp319
41. U Ladabaum K Song 2005 Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand Gastroenterology. 129 4 1151 62 16230069 10.1053/j.gastro.2005.07.059
42. T Flottemesch 2011 C-A5-02: Is Tailored Screening for Colorectal Cancer based on Gender and Race Cost-Effective? Clin Med Res. 9 3-4 174 10.3121/cmr.2011.1020.c-a5-02
43. DK Rex DA Johnson JC Anderson PS Schoenfeld CA Burke JM Inadomi 2009 American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected] Am J Gastroenterol. 104 3 739 50 19240699 10.1038/ajg.2009.104
44. USPST Force 2008 Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 149 9 627 37
45. I Lansdorp-Vogelaar M van Ballegooijen AG Zauber R Boer J Wilschut SJ Winawer, et al. 2009 Individualizing colonoscopy screening by sex and race Gastrointest Endosc 70 1 96 108 19467539 10.1016/j.gie.2008.08.040 e1-24
46. LC Walter CL Lewis MB Barton 2005 Screening for colorectal, breast, and cervical cancer in the elderly: a review of the evidence Am J Med. 118 10 1078 86 16194635 10.1016/j.amjmed.2005.01.063
47. DM Eddy J Adler B Patterson D Lucas KA Smith M Morris 2011 Individualized guidelines: the potential for increasing quality and reducing costs Ann Intern Med 154 9 627 34 21536939
48. RT Villavicencio DK Rex 2000 Colonic adenomas: prevalence and incidence rates, growth rates, and miss rates at colonoscopy Semin Gastrointest Dis. 11 4 185 93 11057946 1:STN:280:DC%2BD3crgs1arsQ%3D%3D
49. LE Johns RS Houlston 2001 A systematic review and meta-analysis of familial colorectal cancer risk Am J Gastroenterol. 96 10 2992 3003 11693338 10.1111/j.1572-0241.2001.04677.x 1:STN:280:DC%2BD3MnjvVWquw%3D%3D
50. V Cottet A Pariente B Nalet J Lafon C Milan S Olschwang, et al. 2007 Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors Gastroenterology. 133 4 1086 92 17919484 10.1053/j.gastro.2007.07.023
51. E Giovannucci GA Colditz MJ Stampfer WC Willett 1996 Physical activity, obesity, and risk of colorectal adenoma in women (United States) Cancer Causes Control. 7 2 253 63 8740738 10.1007/BF00051301 1:STN:280:DyaK28zivVKjug%3D%3D
52. E Giovannucci A Ascherio EB Rimm GA Colditz MJ Stampfer WC Willett 1995 Physical activity, obesity, and risk for colon cancer and adenoma in men Ann Intern Med 122 5 327 34 7847643 1:STN:280:DyaK2M7ltVejug%3D%3D
53. JE Elwing F Gao NO Davidson DS Early 2006 Type 2 diabetes mellitus: the impact on colorectal adenoma risk in women Am J Gastroenterol. 101 8 1866 71 16790036 10.1111/j.1572-0241.2006.00651.x
54. LS Wilson J Lightwood 2001 Model of estimated rates of colorectal cancer from polyp growth by year of surveillance J Med Screen. 8 4 187 96 11743035 10.1136/jms.8.4.187 1:STN:280:DC%2BD3MnpsFSqsw%3D%3D
55. LF Butterly MP Chase H Pohl GS Fiarman 2006 Prevalence of clinically important histology in small adenomas Clin Gastroenterol Hepatol. 4 3 343 8 16527698 10.1016/j.cgh.2005.12.021
56. MJ O'Brien SJ Winawer AG Zauber LS Gottlieb SS Sternberg B Diaz, et al. 1990 The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas Gastroenterology. 98 2 371 9 2403953
57. H Shinya WI Wolff 1979 Morphology, anatomic distribution and cancer potential of colonic polyps Ann Surg. 190 6 679 83 518167 10.1097/00000658- 197912000-00001 1:STN:280:DyaL3c%2Fos1KltQ%3D%3D
58. R Scheiden J Sand M Pandin Y Wagener C Capesius 2000 Colorectal high-grade adenomas: incidence, localization and adenoma-adenocarcinoma ratio in a retrospective and comparative population-based study of 225 consecutive cases between 1988 and 1996 Int J Colorectal Dis. 15 1 29 34 10766088 10.1007/s003840050004 1:STN:280:DC%2BD3c3islWmtw%3D%3D
59. Hermanek P KK. Illustrierte Synopsis kolorektaler Tumore. Pharmazeutische Verlagsanstalt, Munich. 1983.
60. B Hofstad M Vatn 1997 Growth rate of colon polyps and cancer Gastrointest Endosc Clin N Am. 7 3 345 63 9177139 1:STN:280:DyaK2szitVOkug%3D%3D
61. Stein KB, Snyder CF, Barone BB, Yeh HC, Peairs KS, Derr RL, et al. Colorectal Cancer Outcomes, Recurrence, and Complications in Persons With and Without Diabetes Mellitus: A Systematic Review and Meta-Analysis. Dig Dis Sci. 2009.
62. DK Rex 1995 Colonoscopy: a review of its yield for cancers and adenomas by indication Am J Gastroenterol. 90 3 353 65 7872270 1:STN:280: DyaK2M7nslWisA%3D%3D
63. F Loeve ML Brown R Boer M van Ballegooijen GJ van Oortmarssen JD Habbema 2000 Endoscopic colorectal cancer screening: a cost-saving analysis J Natl Cancer Inst. 92 7 557 63 10749911 10.1093/jnci/92.7.557 1:STN:280: DC%2BD3c3hsFSgsw%3D%3D
64. JL Warren CN Klabunde AB Mariotto A Meekins M Topor ML Brown, et al. 2009 Adverse events after outpatient colonoscopy in the Medicare population Ann Intern Med 150 12 849 57 19528563 W152
65. TR Levin W Zhao C Conell LC Seeff DL Manninen JA Shapiro, et al. 2006 Complications of colonoscopy in an integrated health care delivery system Ann Intern Med 145 12 880 6 17179057
66. RM Ness AM Holmes R Klein R Dittus 1999 Utility valuations for outcome states of colorectal cancer Am J Gastroenterol. 94 6 1650 7 10364039 10.1111/j.1572-0241.1999.01157.x 1:STN:280:DyaK1M3ptVOjtQ%3D%3D
67. PW Sullivan V Ghushchyan 2006 Preference-Based EQ-5D index scores for chronic conditions in the United States Med Decis Making. 26 4 410 20 16855129 10.1177/0272989X06290495
68. PW Sullivan V Ghushchyan 2006 Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample Med Decis Making. 26 4 401 9 16855128 10.1177/0272989X06290496